Literature DB >> 18952548

Analysis of atrial fibrillation: from electrocardiogram signal processing to clinical management.

Leif Sörnmo1, Martin Stridh, Daniela Husser, Andreas Bollmann, S Bertil Olsson.   

Abstract

The analysis of atrial fibrillation in non-invasive ECG recordings has received considerable attention in recent years, spurring the development of signal processing techniques for more advanced characterization of the atrial waveforms than previously available. The present paper gives an overview of different approaches to the extraction of atrial activity in the ECG and to the characterization of the resulting atrial signal with respect to its spectral properties. So far, the repetition rate of the atrial waves is the most studied parameter and its significance in clinical management is briefly considered, including the identification of pathomechanisms and prediction of therapy efficacy.

Entities:  

Mesh:

Year:  2009        PMID: 18952548     DOI: 10.1098/rsta.2008.0162

Source DB:  PubMed          Journal:  Philos Trans A Math Phys Eng Sci        ISSN: 1364-503X            Impact factor:   4.226


  3 in total

1.  Predictors of successful cardioversion with vernakalant in patients with recent-onset atrial fibrillation.

Authors:  Natalia Mochalina; Tord Juhlin; Bertil Öhlin; Jonas Carlson; Fredrik Holmqvist; Pyotr G Platonov
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-07-09       Impact factor: 1.468

2.  Non-Invasive Estimation Of Left Atrial Dominant Frequency In Atrial Fibrillation From Different Electrode Sites: Insight From Body Surface Potential Mapping.

Authors:  Marjan Bojarnejad; James R Blake; John Bourke; Ewan Shepherd; Alan Murray; Philip Langley
Journal:  J Atr Fibrillation       Date:  2014-10-31

3.  Using Minimum Redundancy Maximum Relevance Algorithm to Select Minimal Sets of Heart Rate Variability Parameters for Atrial Fibrillation Detection.

Authors:  Szymon Buś; Konrad Jędrzejewski; Przemysław Guzik
Journal:  J Clin Med       Date:  2022-07-11       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.